The expression product of CD44, a non-kinase transmembrane glycoprotein, is a cancer stem cell marker that binds to ligands and induces cell proliferation, increases cell survival and increases cell viability, thereby mediating tumor progression and metastasis 27, 28, 29. This evidence concerns the gene CD44 and cancer.